Latest news from our portfolio companies and the Verge network.
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
RetiSpec closes $10M USD to advance commercialization of its AI-driven eye test for detection of Alzheimer's disease
RetiSpec joins StartUp Health's Alzheimer's Moonshot Community
ViewMind awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award
Endiatx's groundbreaking swallowable robotic pill, Pillbot, featured in VentureBeat
RetiSpec, Topcon Healthcare, Inc. announce collaboration, investment
Load more
